Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026

Core Viewpoint - Amarin Corporation plc is set to report its fourth quarter and full year 2025 financial results on February 25, 2026, followed by a conference call with senior management [1]. Group 1: Financial Reporting - The company will issue a press release detailing its financial results in the pre-market hours on February 25, 2026 [1]. - A conference call is scheduled for 8:00 a.m. ET on the same day to discuss the results [1]. Group 2: Participation Information - Investors can access the live call via telephone in the U.S. by dialing 888-506-0062 or internationally at 973-528-0011, using access code 675507 [2]. - An online webcast will be available on the Investor Relations section of the company's website [2]. - A replay of the call will be accessible via telephone and online after the live call, available until August 25, 2026 [2]. Group 3: Company Overview - Amarin is a global pharmaceutical company focused on reducing the burden of cardiovascular disease (CVD) and advancing cardiovascular care [3]. - The company has a global branded product approved by multiple regulatory authorities, supported by robust clinical trial evidence [3]. - Amarin employs a direct sales approach in the U.S. and an indirect distribution strategy internationally, covering over 90 markets worldwide [3].